Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, v2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    5%
    Check dated 2025-08-02T12:39:12.000Z thumbnail image
  2. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.3%
    Check dated 2025-07-19T11:07:50.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    A service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    4%
    Check dated 2025-07-12T07:27:48.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The page has removed specific future updates regarding the modernization of ClinicalTrials.gov data ingest and the associated API user input opportunity. Additionally, a previous version date and revision number have been deleted.
    Difference
    5%
    Check dated 2025-07-05T02:36:10.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    4%
    Check dated 2025-06-20T18:08:04.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.3%
    Check dated 2025-06-13T15:54:47.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.